Quantcast

HelloLife Announces Release of ADHD Assessment Test

February 21, 2012

Today, HelloLife announced the release of their new, comprehensive ADHD assessment test, overseen by Dr. Jeffrey Chamberlain.

Grand Rapids, MI (PRWEB) February 20, 2012

Today, HelloLife announced the release of their new, comprehensive ADHD assessment test, overseen by Dr. Jeffrey Chamberlain.

The test will allow users to take part in an extensive assessment of ADHD symptoms and a plethora of other features, including: tips on improving ADHD symptoms naturally, chronological tracking of treatment methods, access to blogs by health professionals, and the ability to communicate with other users living with ADHD.

“ADHD has quickly become a cultural phenomenon over the last two decades,” said CEO and President Albert Duoibes, “That being said, the diagnostic process involved with ADHD is still catching up. This assessment will help our users to get a baseline of information that they can then present to their doctor.”

“It is not our intention to provide a diagnosis of ADHD, just to help our users better understand what they may be going through and to help track their treatment progress.”

HelloLife, LLC is an Applied Life Science and Technology company doing business in the fields of health and wellness. The Company operates under Good Manufacturing Practices (GMPs). These are strict, federal manufacturing processes of products for human consumption, such as drugs, dietary supplements and food. GMP standards allow total documentation of all processes, from production to distribution ensuring consistency and high quality.

HelloLife is committed to providing safe relief, nutritional support and education for healthy lifestyle choices. Its headquarters are located at 4460 — 44th St. SE, Ste. C 600, Grand Rapids, MI, 49512. Our products are available to consumers via retailers, health care professionals and direct mail. For more information about the company or our products, visit our website at: http://www.hellolife.net.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/2/prweb9212157.htm


Source: prweb



comments powered by Disqus